Effect of anlotinib combined with ticeorgio for recurrent nasopharyngeal carcinoma: a case report

• Egile Nagusiak: Jiwei Mao (Egilea), Wanli Ye (Egilea), Dongping Wu (Egilea), Jianjiang Liu (Egilea), Ting Li (Egilea), Weili Ma (Egilea), Yang Zhou (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

For patients with locally unresectable recurrent nasopharyngeal carcinoma who relapsed after 2 years of radiotherapy, re-radiotherapy is also the preferred treatment. However, for patients relapsed within 2 years, the use of re-radiotherapy would be greatly limited by its adverse effects. Consequent...